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Summary
Very-low-energy diets (VLEDs) and ketogenic low-carbohydrate diets (KLCDs)
are two dietary strategies that have been associated with a suppression of appetite.
However, the results of clinical trials investigating the effect of ketogenic diets on
appetite are inconsistent. To evaluate quantitatively the effect of ketogenic diets on
subjective appetite ratings, we conducted a systematic literature search and meta-
analysis of studies that assessed appetite with visual analogue scales before (in
energy balance) and during (while in ketosis) adherence to VLED or KLCD.
Individuals were less hungry and exhibited greater fullness/satiety while adhering
to VLED, and individuals adhering to KLCD were less hungry and had a reduced
desire to eat. Although these absolute changes in appetite were small, they
occurred within the context of energy restriction, which is known to increase
appetite in obese people. Thus, the clinical benefit of a ketogenic diet is in
preventing an increase in appetite, despite weight loss, although individuals may
indeed feel slightly less hungry (or more full or satisfied). Ketosis appears to
provide a plausible explanation for this suppression of appetite. Future studies
should investigate the minimum level of ketosis required to achieve appetite
suppression during ketogenic weight loss diets, as this could enable inclusion of a
greater variety of healthy carbohydrate-containing foods into the diet.
Keywords: Appetite, ketogenic diet, ketosis, low carbohydrate, very-low-energy
diet, visual analogue scale.
Abbreviations: CCK, cholecystokinin; CHO, carbohydrate; KLCD, ketogenic
low-carbohydrate diet; PYY, peptide YY; VAS, visual analogue scale; VLED,
very-low-energy diet.
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Introduction
Hunger is a major side effect of weight loss attempts, and,
if the plethora of over-the-counter weight loss products
and diet books claiming that you can ‘diet without
hunger’ is anything to go by, it is also the most profitable.
Compensatory increases in hunger (and appetite gener-
ally) in response to energy-restricted diets probably con-
tribute to the high rate of attrition in weight loss attempts
and the inability of individuals to maintain weight loss
(1–4). These compensatory changes in appetite during
weight loss are thought to be induced by alterations in
expression of hypothalamic regulators of energy balance
(5) as well as adaptive changes in gut function, which
alter the concentration of appetite-regulating hormones,
such as ghrelin (6–9), cholecystokinin (CCK) (8–10) and
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peptide YY (8,9,11). Thus, finding ways to ‘block’ the
compensatory increase in appetite associated with energy-
restricted diets represents the ‘holy grail’ of weight
management.
Two dietary strategies that may suppress appetite are
very-low-energy diets (VLEDs), which provide less than
3.4 MJ (800 kcal) per day (12), and ketogenic low-
carbohydrate diets (KLCDs), which severely restrict dietary
carbohydrate intake but allow ad libitum consumption of
protein and fat. Paradoxically, despite severe energy restric-
tion and rapid weight loss (12), VLEDs are frequently cited
in the literature (13–18) and promoted in the lay press (19)
as suppressing appetite. The efficacy of KLCDs is also often
attributed to a suppression of appetite resulting in sponta-
neous decrease in energy intake (20–24). However, there is
conjecture in the literature regarding whether, and how,
VLEDs or KLCDs alter appetite. Studies have reported an
increase (25,26), no change (10,17,24,27–30) and/or a
decrease (13,14,20,28,31–33) in appetite during adherence
to such diets. Thus, there is a need for stronger evidence
base before we can conclude that VLEDs or KLCDs really
do suppress appetite.
The supposed appetite suppression seen with both
VLEDs and KLCDs is often hypothesized to be due to
ketosis (15,34–39). Ketosis is a condition where the pro-
duction of ketone bodies or ‘ketones’ (β-hydroxybutyrate,
acetoacetate and acetone that are produced in the liver by
ß-oxidation of free fatty acids) is increased, leading to
elevations in their circulating concentrations. Ketosis is a
coordinated metabolic response that provides an alterna-
tive fuel source derived from fat when glucose is in short
supply. The level of circulating ketones is primarily deter-
mined by carbohydrate intake and the action of insulin.
Modern VLEDs and KLCDs, respectively, provide approxi-
mately 40–60 and 20 g (initially) of dietary carbohydrate
per day. Although both VLEDs and KLCDs typically
result in ketosis, KLCDs can result in several fold
higher circulating levels of ketones than VLEDs (20,29).
Although ketosis is purported to be responsible for the
appetite suppression associated with VLEDs and KLCDs,
carbohydrate-restricted diets are counter-intuitive to
evidence-based healthy eating guidelines as they involve
elimination of whole groups of foods, and in particular
those that are beneficial for health and/or weight manage-
ment (i.e. whole grains, legumes, reduced-fat dairy, fruit)
(40–42). Thus, if ketosis is indeed associated with suppres-
sion of appetite, it is pertinent to explore at what level of
carbohydrate intake and circulating ketone levels this
occurs, because such severe restriction of carbohydrate may
not be necessary to prevent a compensatory increase in
appetite. Indeed, there may be a ‘threshold’ for an appetite-
suppressive effect at lower levels of ketosis (and accord-
ingly a more liberal carbohydrate intake could potentially
be allowed in the weight loss diet).
In light of current conjecture about the effect of
ketogenic diets on appetite, the fact that VLEDs are fre-
quently used and recommended for the treatment of
obesity, as well as renewed interest in high protein, very-
low-carbohydrate diets, clinicians and patients need clear,
evidence-based information about what actually works
for appetite suppression during weight loss interventions.
Hence, we conducted a systematic review and meta-
analysis to determine the effect of ketogenic diets on appe-
tite. We specifically included dietary intervention studies
that employed a within-subject, repeated measure of appe-
tite before (when participants were in energy balance)
and during (when participants were in ketosis) adherence
to VLED or KLCD. A secondary aim was to use meta-
regression to explore whether a dose–response or threshold
effect existed between circulating ketone levels and
appetite.
Methods
Selection criteria of studies for this review
Studies were included if they assessed subjective ratings of
appetite in adults before (‘baseline’) and during adherence
to VLED or KLCD in at least one study arm. We limited
studies to those that assessed subjective appetite using
visual analogue scale (VAS) questionnaires. VASs are a
standardized and validated (43) system of appetite assess-
ment that requires a response to a question such as ‘How
hungry do you feel now?’ to be marked on a line (usually
100 mm in length) anchored at each end with opposing
statements such as ‘Not at all’ and ‘Extremely’ (44). For
inclusion in the meta-analyses, the baseline assessment had
to be performed when participants were in energy balance
(e.g. had not been on an energy-restricted diet prior to
baseline assessment). We included randomized and non-
randomized studies, provided that the study employed a
within-subject, repeated measure for appetite assessment.
The reason for this is that within-subject comparisons of
appetite are considered to be more sensitive and accurate
than between-subject comparisons (45).
We defined a ‘ketogenic’ diet as one that raised fasting
blood concentrations of β-hydroxybutyrate to ≥0.3 mM (a
level that is greater than that induced by an overnight fast
∼0.1 mM and that has been associated with appetite sup-
pression [29]), or in which participants tested positive for
ketones in the urine using dipsticks. To reduce publication
bias, we also included studies that did not measure or
report blood or urinary ketone concentrations, but for
which it was highly likely that participants were in ketosis.
This was determined by comparing the rate of weight loss
in the study with rates of weight loss arising from known
ketogenic diets in similar populations, as well as consider-
ing the prescribed energy and carbohydrate composition of
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the intervention, or the circulating concentration of free
fatty acids, which is known to be increased during ketosis.
The specific rationale for each study included is detailed in
Table S1 in the online supplementary file.
We excluded duplicate studies, studies where the inter-
vention involved pharmacotherapy, if appetite was only
assessed at baseline or if appetite was not assessed at
baseline.
Search strategy
We searched electronic databases, namely, MEDLINE,
PreMEDLINE, PubMed, Embase and PsycINFO, from
inception until 13 December 2013 for original human
research articles published in English. The reference lists of
included studies were also searched. We employed a com-
prehensive search strategy combining two groups of key
words (MeSH terms and/or free text) related to the type of
intervention and outcome:
• Low carb* OR Diet, carbohydrate-restricted OR diet,
reducing OR very low energy diet OR very low calorie diet
OR protein sparing modified fast OR ketogenic diet OR
ketogenic OR ketosis OR ketone bodies OR ketones
• Appetite OR hunger OR satiation OR satiety OR
desire to eat OR visual analogue scale
Data collection and analysis
Selection of studies
Records were screened independently by two investigators
(AAG and JA) at the abstract and title level. The full texts
of potentially eligible studies were obtained and these two
investigators applied the inclusion and exclusion criteria
independently. Discrepancies were resolved by consensus
with a third author (RVS).
Data extraction
We developed a data extraction sheet, which was pilot
tested and refined accordingly. One author (AAG)
extracted the data from all studies and a second author (JA)
checked all data entry for accuracy.
Information was extracted from each included study on
(i) study characteristics (primary author, year of publica-
tion, setting, duration [point of follow-up appetite assess-
ment] and nutritional composition of intervention); (ii)
baseline characteristics of the study population (sample
size, sex, age, body mass index); (iii) weight loss outcomes;
(iv) appetite assessment method and results (aspects
[hunger, fullness etc.], time of day, frequency, reference
period [i.e. ‘present’ – how hungry do you feel now; or
‘retrospective’ – how hungry did you feel today/this
week?]), reporting format (i.e. single time point or average
of several time points), results (all in mm out of 100);
and, if applicable, (v) methodology for assessing ketones
and results (type [blood or urine; β-hydroxybutyrate,
acetoacetate or acetone], time points, results). Where infor-
mation was missing, we contacted authors for further
information.
Data synthesis
In studies that randomized participants after the point in
the intervention that was of interest for this meta-analysis,
we pooled the intervention groups if they received the same
ketogenic intervention up until the relevant time point (i.e.
if participants were randomized to a weight maintenance
intervention after 4–6 weeks on VLED, we were only inter-
ested in the data before and while adhering to the VLED)
(46–52). One study included multiple ketogenic interven-
tion arms (i.e. VLEDs differing in protein, fat or carbohy-
drate content), and we included all arms of that study as
separate comparisons (53). We only identified two studies
that compared a ketogenic diet with a non-ketogenic diet
that also met our other inclusion criteria (20,54). However,
the non-ketogenic comparison groups in these two studies
were too dissimilar to be combined in a meta-analysis, and
only one of these studies (20) used participants as their own
control. Therefore, we only extracted information from
ketogenic interventions and thus, all studies included in this
meta-analysis provided data of ‘pre-test’ vs. ‘post-test’.
It was our intention to include the five primary aspects of
appetite as recommended by Blundell in 2010; fullness,
satiety, hunger, desire to eat and prospective consumption
(44). However, due to inconsistencies in terminology and
the lack of reporting of questions used to assess these
aspects of appetite, we had to make adjustments to the data
from some studies. We combined analysis of studies that
assessed ‘fullness’ (20,29,53) and those that assessed
‘satiety’ (47–52) into a single variable of ‘fullness/satiety’.
In one study that reported both fullness and satiety (55), we
pooled the results into one variable. Although fullness and
satiety may measure subtly different aspects of appetite,
they are related to each other (43) and would be expected
to change in the same direction.
To calculate nutritional composition of interventions a
conversion of 17 kJ g−1 for protein and carbohydrate and
37 kJ g−1 for fat was applied to studies that reported nutri-
tional composition as a percentage of energy. Kilocalories
were converted to kJ by multiplying by 4.18. For the dura-
tion of intervention, we assumed 1 month to equal 4 weeks.
Data synthesis and analysis
Primary outcomes
The primary outcomes were the weighted mean difference
in change in appetite (mm on a 100-mm scale) between
baseline (when participants were in energy balance) and
during adherence to VLED or KLCD (when participants
OBR12230
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were in ketosis). A random effects model was used to
estimate separate effect sizes for fullness/satiety, hunger,
desire to eat and prospective consumption. Changes in
appetite variables were calculated by subtracting the mean
rating measured during adherence to VLED or KLCD from
the mean rating measured at baseline, so that the difference
(positive or negative) would reflect the direction of change
in appetite. For example, a negative difference for hunger
and a positive difference for fullness/satiety both represent
a decrease in appetite.
Secondary outcome
Meta-regression aims to relate the size of an effect to char-
acteristics (potential ‘effect modifiers’) of the studies
involved (56). Therefore, a secondary outcome was to
use meta-regression to determine whether the change in
appetite (as calculated above) was associated with the
level of ketosis, i.e. whether higher circulating levels of
β-hydroxybutyrate resulted in a greater difference in appe-
tite. Meta-regression was to be performed only if hetero-
geneity was found to be present among studies, as this
would indicate whether differences in the effect in each
study existed.
Heterogeneity, risk of bias and quality assessment
Heterogeneity between studies was assessed using the I2
statistic. Egger’s test was used to investigate possible pub-
lication bias. Statistical significance was set at P < 0.10.
The usual quality filters for randomized trials or observa-
tional epidemiologic studies were not applied to the studies
selected for this work, as only ‘pre-test’ vs. ‘post-test’ data
were assessed.
All statistical analyses were conducted using STATA soft-
ware version 13.0 (StataCorp, College Station, TX, USA).
Results
Study selection
The systematic search resulted in 26 publications that met
the inclusion criteria, 12 of which were included in the
meta-analysis (Fig. 1). Fourteen publications were included
in the review but were not included in the meta-analysis,
nine did not have the required data (13,17,24–26,30,32)
and five conducted baseline assessment of appetite when
participants were not in energy balance (14,27,28,31,33).
These publications excluded from the meta-analysis were
reviewed qualitatively.
Characteristics of studies included in
the meta-analysis
Interventions
The characteristics of studies included in the meta-analysis
(n = 12) are shown in Table 1. All but one of these studies
was conducted entirely in an outpatient setting, with the
duration of all the ketogenic interventions ranging from 4
to 12 weeks. The studies used different terminology to
describe the interventions, and for consistency the term
VLED is used to refer to all interventions providing less
than 3.3 MJ (800 kcal) per day, and the term KLCD is used
when referring to interventions that restricted carbohydrate
intake to <10% of energy or ≤50 g day–1, but that allowed
ad libitum consumption of energy, protein and fat. Ten
studies involved VLED interventions, and they prescribed
similar daily intakes of energy (∼2.1–2.4 MJ), protein (50–
60 g), carbohydrate (45–52 g) and fat (<10 g) (29,30,46–
52). There were slight differences in one study that
provided varying daily protein (64–97 g), fat (2–23 g) and
carbohydrate (28–42 g) intakes in the intervention groups
(53). No studies reported the fibre content of the diet. All of
the VLED studies allowed additional servings of fruit and
vegetables (46,48–52), but more specific information was
not reported; therefore, dietary prescriptions reported
in Table 1 do not include these allowances. All studies
Figure 1 Flowchart of publication selection for the systematic review
and meta-analysis. VAS, visual analogue scale.
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involving VLED reported average weight losses of greater
than 1 kg week–1 and most commonly reported a mean
weight loss of ∼6 kg (range 5.0–12.5 kg) at the time of the
appetite assessment. The remaining three studies used
KLCD intervention (20,54,55). Although participants were
not instructed to restrict their energy intake, it appeared
that they did so in all three KLCD studies, as evidenced by
mean weight losses of 6.3–9.5 kg. One study was a well-
controlled in-patient study, where participants reduced
their daily energy intake by 5.4 MJ (20), while the other
two did not report energy intake.
Participants
Sample sizes in the different studies ranged from 17 to 148.
Where reported, studies had a greater proportion of
women than men. Participants in the 12 studies had similar
ages (ranging from 30 to 55 years) and were overweight or
obese (body mass index ≥25 kg m−2). Information relating
to the participants in each study is provided in Table 1.
Appetite methodology
Methods of appetite assessment used in the 12 studies
included in this meta-analysis, and the aspects of appetite
assessed, are shown in Table 2. The majority of studies
(n = 8) assessed appetite in the morning in the fasted state.
One study also assessed appetite after a standardized meal
and reported area under the curve, but only the fasted
appetite value was included in the meta-analyses for com-
parison with the other studies (29). Most VAS questions
were asked in reference to the present state (e.g. ‘How
hungry do you feel now?’) (n = 11) vs. retrospective
enquiry (e.g. ‘How hungry were you this week?’) (n = 1).
The results were typically reported in the format of a single
time point (n = 9) or, depending on the time points at which
appetite was assessed, as an average of several time points
on the same day (n = 3) or over several days (n = 1). All
studies reported results in mm on a 100-mm scale or cm on
a 10-cm scale (which were converted to mm for the current
meta-analysis).
Ketones
In studies included in the meta-analysis, ketosis was con-
firmed through objectively measured blood or urinary
parameters. Table 3 shows the levels of β-hydroxybutyrate
in the blood of participants at the time of appetite assess-
ment while on the ketogenic diet, in the nine studies in
which it was reported. All but one of these studies
involved VLEDs, and the prescribed daily carbohydrate
intake ranged from 45 to 52 g (not including fruit
and vegetable allowances), resulting in similar (∼0.5 mM)
blood β-hydroxybutyrate levels. Levels of blood
β-hydroxybutyrate were several fold higher in the KLCD
Table 2 Protocol for appetite assessment via visual analogue scales in the 12 studies included in the meta-analysis of effects of ketogenic diets on
subjective appetite
Study Aspects of appetite Time of day Reference Reporting format Assessment time
points
Diepvens et al. (46) Hunger Morning/fasted and at 60,
120, 180 and 240 min
after 1 MJ of yoghurt
Present Average over 4 h (five
measurements)
Baseline, week 6
Hursel and
Westerterp-
Plantenga (47)
Satiety, hunger Morning/fasted Present Single measurement Baseline, week 4
Johnstone et al. (20) Fullness, hunger, desire to eat,
prospective consumption
Hourly during waking
hours (08:00–22:00 h)
Present Average of 15 daily
measurements
Daily for 4 weeks
Kovacs et al. (48) Satiety, hunger Morning/fasted Present Single measurement Baseline, week 4
Lejeune et al. (50) Satiety, hunger Morning/fasted Present Single measurement Baseline, week 4
Lejeune et al. (49) Satiety, hunger Morning/fasted Present Single measurement Baseline, week 4
Martin et al. (54) Hunger NR Retrospective
(1 week)
Single measurement Baseline, week 12
Ratliff et al. (55) Fullness, satiety, hunger, desire
to eat
NR Present Average of 5 days Baseline, week 12
Soenen et al. (53) Fullness, hunger, desire to eat,
prospective consumption
Morning/fasted Present Single measurement Baseline, week 4
Sumithran et al. (29) Fullness, hunger, desire to eat,
prospective consumption
Morning/fasted Present Single measurement Baseline, week 8
Westerterp-Platenga
et al. (51)
Satiety, hunger Morning/fasted Present Single measurement Baseline, week 4
Westerterp-Platenga
et al. (52)
Satiety, hunger Morning/fasted Present Single measurement Baseline, week 4
NR, not reported.
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intervention, in which participants consumed 22 g of car-
bohydrate per day (20). In the three studies included
in the meta-analysis that did not report on blood
β-hydroxybutyrate levels, two confirmed ketosis using
urinary dipsticks (54,55). In one remaining study (53),
ketones were not measured, but the reported increase in
circulating free fatty acid concentrations were consistent
with those reached during ketosis.
Main findings from the meta-analyses
Very-low-energy diet studies
A forest plot of the nine studies examining the effect of
VLED on appetite is depicted in Fig. 2. All of these nine
VLED studies assessed fullness/satiety. Individually, there
were only four studies that found a significant increase in
fullness/satiety. However, when data from all studies were
considered in the meta-analysis, overall fullness/satiety
increased by 6.5 mm (95% confidence interval [CI]: 4.3,
8.8). All of the VLED studies assessed hunger. Individually,
none of these studies found a significant decrease in
hunger during adherence to the VLED. When considering
all studies in the meta-analysis overall, however, hunger
decreased by 2.6 mm (95% CI: −4.9, −0.2). Only two
studies assessed desire to eat and prospective consumption,
which did not change significantly. No heterogeneity
(I2 = 0.0%) was detected in any of the analyses. Egger’s
test for publication bias was significant for desire to eat
(P = 0.06).
Ketogenic low-carbohydrate diet studies
A forest plot of the three studies examining the effect of
KLCDs on appetite is depicted in Fig. 3. Only two of the
studies assessed fullness/satiety, which did not increase
significantly. All three studies assessed hunger, which
decreased significantly by 5.5 mm (95% CI: −8.5, −2.5).
Two studies assessed desire to eat, which decreased
by 8.9 mm (95% CI: −16.0, −1.8). No heterogeneity
(I2 = 0.0%) or publication bias was detected in any of the
analyses.
Meta-regression
Meta-regression was not performed as the level of
β-hydroxybutyrate was similar among all VLED stu-
dies (∼0.5 mM) and only one KLCD diet measured
β-hydroxybutyrate.
Qualitative evaluation of studies not included in
the meta-analysis
Tables S2 and S3 in the online supplementary file provide
detailed information on the intervention and participant
characteristics, and appetite assessment methodology,
respectively, of 14 studies that were excluded from the
meta-analysis.
Nine studies (eight VLED, one KLCD) were excluded
from the meta-analysis due to unavailability of data in the
format used here. Of these, seven studies support the find-
ings of the meta-analysis as they reported a significant
decrease (13,32) or no significant change (10,17,24,57) in
hunger, and one study reported no change in fasting hunger
or satiety but significant decreases in hunger and increases
in satiety when measured 2 h post-prandially (30). Two
studies did not support the findings of the meta-analysis as
they reported significant increases in hunger on VLED.
However, in one study the appetite score was an average of
scores taken over 2 weeks, which included the first few days
on the VLED, in which appetite is known to be increased
(25). In the other of these two VLED studies, despite
reporting a significant increase in hunger, participants did
not exhibit greater energy intake at a breakfast meal (26).
Five studies (all VLEDs) were excluded from the
meta-analysis because the baseline assessment of appetite
was not conducted under conditions of energy balance,
Table 3 Degree of ketosis attained in the nine studies included in the meta-analysis that also reported blood concentrations of β-hydroxybutyrate
Study Ketogenic
diet type
Prescribed CHO
intake (g day–1)
Time point
(weeks)
n β-Hydroxybutyrate
mM (mean ± SD)
Diepvens et al. (46)* VLED 52 6 50 0.49 ± 0.38
Hursel and Westerterp-Plantenga (47)* VLED 52 4 80 0.56 ± 0.24
Johnstone et al. (20) KLCD 22 4 17 1.52 ± 1.64
Kovac et al. (48)* VLED 52 4 104 0.50 ± 0.30
Lejeune et al. (50)* VLED 52 4 91 0.53 ± 0.31
Lejeune et al. (49)* VLED 52 4 113 0.51 ± 0.32
Sumithran et al. (29)* VLED 45 8 39 0.48 ± 0.44
Westerterp-Platenga et al. (51)* VLED 52 4 148 0.50 ± 0.32
Westerterp-Platenga et al. (52)* VLED 52 4 76 0.50 ± 0.08
*Intervention included fruit and/or vegetable allowance, and this was not included in the carbohydrate information shown.
CHO, carbohydrate; KLCD, ketogenic low-carbohydrate diet; SD, standard deviation; VLED, very-low-energy diet.
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but was instead preceded by an energy-restricted diet
(14,27,28,31,33). Compared with the baseline assessment
of hunger measured during moderate-energy restriction,
while adhering to VLED, participants in three studies
showed significantly decreased hunger (14,31,33), partici-
pants in one study showed no change in hunger (27) and
participants in another study on a liquid VLED showed no
change in hunger and participants on the food-based VLED
showed a significant decrease in hunger (28). That is, in all
five of these excluded VLED studies, participants were
either less hungry or were no hungrier while on the VLED
compared with after the moderately energy-restricted diet.
Although these studies are not directly comparable, with
those included in the meta-analysis, they support the find-
ings of the meta-analysis by showing that there was no
increase in appetite while adhering to VLED.
Discussion
This study showed that individuals are significantly less
hungry and exhibit significantly greater fullness/satiety
while adhering to VLED compared with when they are in
energy balance at baseline. This work also showed that
individuals adhering to KLCD are significantly less hungry
and have a significantly reduced desire to eat compared
with baseline measures. Although the absolute changes in
subjective appetite measures during VLED or KLCD may
be considered small, and for some aspects of appetite
were not significant, the more remarkable finding from
this work, from a clinical perspective, is the clear lack
of increase in hunger despite participants consuming
a severely (in the case of VLEDs) or moderately (in the
case of KLCDs) energy-restricted diet, and having lost
Figure 2 Forest plot of change in appetite
assessed with visual analogue scales
between baseline and in response to a
very-low-energy diet. Eight studies (10
comparisons; n = 738) assessed
fullness/satiety, nine studies (11 comparisons;
n = 788) assessed hunger, two studies (four
comparisons; n = 126) assessed desire to eat
and two studies (four comparisons; n = 126)
assessed prospective consumption. Plotted
values are weighted mean differences (WMD)
from a random effects model. Error bars
depict 95% confidence intervals (CI). The I2
statistic refers to heterogeneity.
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significant amounts of weight. Thus, for clinicians seeking
an effective method of weight loss that does not increase
hunger, this meta-analysis provides clear evidence that
VLEDs achieve this target. KLCDs also appear promising
but, due to the limited number of these studies available for
the present review, further investigation is needed.
A secondary aim of this work was to determine whether
there is a dose–response or ‘threshold’ of circulating ketone
levels for appetite suppression. However, it was not pos-
sible to realize this aim because there was a lack of differ-
ence in β-hydroxybutyrate levels among VLED studies and
there was only one KLCD study that reported blood
β-hydroxybutyrate levels. Nevertheless, it is important
to note that the VLED studies that measured circulating
ketone levels included in the meta-analysis showed blood
β-hydroxybutyrate levels of ∼0.5 mM, and none reported
an increase in appetite. This finding suggests that if a
threshold of circulating β-hydroxybutyrate for appetite
control exists, it may be lower than 0.5 mM, and that
higher levels (and accordingly more severe dietary carbo-
hydrate restriction) may not be necessary to prevent an
increase in appetite in response to energy restriction. Unfor-
tunately, the carbohydrate intake required to achieve this
level of ketosis cannot be inferred from the current dataset.
Although all VLED studies provided approximately 50 g of
carbohydrate per day (in formulated meal replacement
products), these interventions also included additional
allowances of fruits and vegetables, for which the nutri-
tional information was not provided. Further support
for the notion of a threshold of circulating ketone concen-
trations for the effect on appetite comes from studies
that have investigated appetite in response to varying
levels of ketosis. These studies found no difference in
appetite between groups with higher or lower levels
of ketosis (17,33,35,57,58), as indicated by circulating
β-hydroxybutyrate concentrations of ∼3.7 or 0.5–0.7 mM,
respectively (17,57). The question whether appetite
can be suppressed during weight loss at a low threshold of
ketosis warrants investigation, as it would enable develop-
ment of KLCDs that are more aligned with evidence-based
healthy eating recommendations through inclusion of
healthy (i.e. low glycaemic index) carbohydrate-containing
foods such as whole grains, legumes, reduced-fat dairy and
fruit.
From the current studies, it was not possible to determine
whether the appetite suppression seen with ketogenic diets
is indeed due to ketosis, or due to other factors such as
an increased or decreased content of protein or fat in the
diet or the restriction of carbohydrate. This is because the
dietary intake of one particular macronutrient cannot be
varied independently of the other macronutrients without
affecting energy. For instance, the appetite suppression of
KLCDs has been attributed to their high protein content
(59). However, KLCDs involve only modest or no increases
in absolute protein intake relative to normal diets (34,60).
Moreover, increased protein intake cannot explain why
appetite is suppressed during VLEDs, which, while rela-
tively high in protein, provide absolute protein intakes of
only ∼50–60 g day–1 (which for obese persons is lower than
the suggested normal intake of 0.8–1.2 g kg−1 body weight
per day [39]). Additionally, increased protein intake cannot
explain the observation of an ‘absence of hunger’ during
starvation or fasting regimes (35,61) – an observation that
historically led to the initial development VLEDs to mimic
this benefit (15). Further, well-controlled studies have
shown that when protein intake is matched, a ketogenic
high-protein diet suppresses appetite more so than a non-
ketogenic high-protein diet in obese (20) and in lean
Figure 3 Forest plot of change in appetite
assessed with visual analogue scales
between baseline and in response to a
ketogenic low-carbohydrate diet. Two studies
(two comparisons; n = 45) assessed
fullness/satiety, three studies (three
comparisons; n = 179) assessed hunger and
two studies (two comparisons; n = 45)
assessed desire to eat. Plotted values are
weighted mean differences (WMD) from a
random effects model. Error bars depict 95%
confidence intervals (CI). The I2 statistic
refers to heterogeneity.
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subjects (62), highlighting ketosis as a plausible factor
common to both VLEDs and KLCDs that could suppress
appetite. Besides protein, another factor that could conceiv-
ably explain the effect of ketogenic diets on appetite is
dietary fat (63). However, the contrasting low levels of
dietary fat intake during VLEDs with the relatively higher
levels consumed during KLCDs suggest that dietary fat
intake is not a common factor explaining the appetite-
suppressive effect of both diets.
One line of evidence that ketosis plays a role in appetite
suppression during both VLEDs and KLCDs is the obser-
vation that changes in perceived appetite and circulating
concentrations of hormonal regulators of appetite coincide
with increased or decreased concentrations of circulating
ketones. For instance, appetite is increased during the first
couple of days on VLED (or on a fasting regime), before
marked increases in circulating ketone concentrations
would be expected to occur (13,15,25,58). However,
after the time when elevated circulating ketone levels are
observed, perceived appetite (10,29,55) and circulating
concentrations of hormonal regulators of appetite, namely,
ghrelin (29,55) and CCK (10,14,29), have been shown to
be no different from pre-VLED and/or pre-KLCD levels.
Further, a study of people on VLED showed that circulating
concentrations of the hunger-promoting hormone ghrelin
were suppressed relative to baseline concentrations only in
those participants who were in ketosis (defined as blood
β-hydroxybutyrate levels ≥0.3 mM), with those who were
not in ketosis showing an increase in circulating ghrelin
levels relative to baseline (29). Consistent with the above
observations is the finding that after a period of re-feeding
that abolishes ketosis post-VLED, perceived appetite and
circulating levels of ghrelin increased, whereas that of the
appetite-suppressing hormone CCK decreased, compared
with the levels found at baseline and in energy balance
(10,29). The above studies provide support for the hypoth-
esis that the now well-established changes in appetite, as
well as the effect of changes in circulating levels of appetite-
regulating hormones that have been shown to accompany
diet-induced weight loss (1–4,8,9,42,64), appear to be
‘blocked’ during ketosis. There may be other factors (such
as the protein, fat or carbohydrate content of the diet
per se) contributing to the suppression of appetite during
VLED or KLCD, but none of these dietary factors provides
as consistent an explanation as ketosis for the appetite
suppression in both diets.
Another line of evidence that ketosis is associated with
appetite suppression (inferred from a reduction in energy
intake and/or subjective appetite ratings) is that studies
have shown elevations in circulating ketones and/or free
fatty acids (two metabolites that are characteristically
increased during fasting and therefore ketosis) affect appe-
tite in humans (65,66) and animals (67–71). Recent studies
have investigated the safety and tolerability of synthetic
ketone esters (72,73). Although synthetic ketone esters
were not developed for the purpose of appetite suppression,
using them to artificially induce mild ketosis could be a
novel strategy for weight management. For instance, if
patients were able to reap the benefits of appetite suppres-
sion with ketosis while consuming a more balanced and
sustainable dietary regime than a KCLD, they could poten-
tially benefit from improved weight outcomes as well as
avoiding potential side effects of long-term dietary imbal-
ances (37,74,75). After all, VLEDs are only intended for
short-term (several months) use, and the weight regain seen
with KLCDs could be related to the unsustainably restric-
tive nature of the diet, as indicated by studies showing poor
long-term adherence (76). However, whether treatment
with exogenous ketones per se could suppress any increase
in appetite or corresponding changes in appetite-regulating
hormones remains to be seen, there are a multitude of
metabolic and hormonal changes associated with ketosis
that could be having an effect on appetite.
A limitation of this work is that we only evaluated
studies by comparing ‘pre-test’ and ‘post-test’ data as we
only identified two studies that used a within-subject
comparison that compared a ketogenic diet with a non-
ketogenic diet (20,54). Further, we only identified three
KLCD studies that compared subjective appetite ratings
with VAS despite a plethora of studies comparing weight
loss outcomes between ketogenic and non-ketogenic diets.
Another limitation of this work is that subjective appetite
assessed with VAS is not necessarily synonymous with
energy intake. However, the fact that people can actually
adhere to VLEDs for several weeks to months at a time, as
evidenced by the rapid and large weight losses achieved
(12), suggests that they do indeed suppress any compensa-
tory increase in appetite.
Conclusion
This systematic review and meta-analysis provides evidence
that VLEDs significantly reduce appetite during weight
loss. KLCD also show promise, but only a limited number
of studies have addressed this question within the scope of
our review. The findings of this study have important impli-
cations for the communication of information by clinicians
to patients. Based on this meta-analysis, clinicians can
advise patients that although they may indeed feel slightly
less hungry (or more full or satisfied) while on VLED, the
true benefit of VLED is in preventing an increase in appe-
tite, and that this can help them to comply with a severe
restriction of energy intake in order to achieve substantial
weight losses, rather than the absence of hunger altogether.
Although other contributory factors cannot be ruled out,
ketosis appears to provide a plausible explanation for the
suppression of appetite during adherence to a ketogenic
diet. Future studies should investigate the minimum level of
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ketosis (and associated carbohydrate intake) to achieve
this effect. From the present data, however, it would seem
unnecessary to restrict carbohydrate intake to less than
50 g day–1 or to achieve blood β-hydroxybutyrate levels
much greater than 0.5 mM, at least during VLED.
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